Structure-based calculation of drug efficiency indices

MOTIVATION The efficiency indices (EI's) have been derived from the experimental binding affinities of drug candidates to macromolecules. These 'two-in-one' measures include information on both pharmacodynamics and pharmacokinetics of the candidate molecules. The time-consuming experimental measurement of binding affinities of extensive molecule libraries may become a bottle-neck of large scale generation and application of EI's. RESULTS To overcome this limitation, structure-based calculation of new EI's is introduced using the modified free energy function of the popular program package AutoDock. The results are validated on experimental binding data of biochemical systems such as potent inhibitors bound to beta-secretase, a key enzyme of Alzheimer's disease and various drug-protein complexes. Application of new EI's is tested. Thermodynamics of EI's and their role in virtual high-throughput screening of drugs and in the development of docking programs are discussed. SUPPLEMENTARY INFORMATION Accompanies this manuscript on the publisher's web site.

[1]  Michael K Gilson,et al.  Concepts in receptor optimization: targeting the RGD peptide. , 2006, Journal of the American Chemical Society.

[2]  Kenneth P. Murphy,et al.  Predicting Binding Energetics from Structure : Looking Beyond , 1999 .

[3]  C. Sander,et al.  An effective solvation term based on atomic occupancies for use in protein simulations , 1993 .

[4]  F. Segal,et al.  A CHARACTERIZATION OF FIBRANT SEGAL CATEGORIES , 2006, math/0603400.

[5]  S. Noskov,et al.  Free energy decomposition of protein-protein interactions. , 2001, Biophysical journal.

[6]  Renxiao Wang,et al.  The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures. , 2004, Journal of medicinal chemistry.

[7]  D. Swinney,et al.  Biochemical mechanisms of drug action: what does it take for success? , 2004, Nature Reviews Drug Discovery.

[8]  David S. Goodsell,et al.  A semiempirical free energy force field with charge‐based desolvation , 2007, J. Comput. Chem..

[9]  A. Hopkins,et al.  Navigating chemical space for biology and medicine , 2004, Nature.

[10]  M. Randic.  Characterization of molecular branching , 1975 .

[11]  J. T. Metz,et al.  Ligand efficiency indices as guideposts for drug discovery. , 2005, Drug discovery today.

[12]  Marcel L. Verdonk,et al.  The consequences of translational and rotational entropy lost by small molecules on binding to proteins , 2002, J. Comput. Aided Mol. Des..

[13]  Jinn-Moon Yang,et al.  Protein structure database search and evolutionary classification , 2006, Nucleic acids research.

[14]  I. Kuntz,et al.  Inclusion of Solvation in Ligand Binding Free Energy Calculations Using the Generalized-Born Model , 1999 .

[15]  I. Kuntz,et al.  The maximal affinity of ligands. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  H. Wiener.  Structural determination of paraffin boiling points. , 1947, Journal of the American Chemical Society.

[17]  David S. Goodsell,et al.  Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.4 , 1996, J. Comput. Aided Mol. Des..

[18]  M. Karelson.  Molecular descriptors in QSAR/QSPR , 2000 .

[19]  A. Balaban.  Highly discriminating distance-based topological index , 1982 .

[20]  Pengyu Y. Ren,et al.  Polarizable Atomic Multipole Water Model for Molecular Mechanics Simulation , 2003 .

[21]  Jens Carlsson,et al.  Absolute and relative entropies from computer simulation with applications to ligand binding. , 2005, The journal of physical chemistry. B.

[22]  Peter Ertl,et al.  Relationships between Molecular Complexity, Biological Activity, and Structural Diversity , 2006, J. Chem. Inf. Model..

[23]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[24]  D. Swinney,et al.  Biochemical Mechanisms of New Molecular Entities (NMEs) approved by United States FDA during 2001‐2004: Mechanisms leading to optimal efficacy and safety. , 2006, Current topics in medicinal chemistry.

[25]  György M Keseru,et al.  Hit discovery and hit-to-lead approaches. , 2006, Drug discovery today.

[26]  Dennis H. Rouvray.  Computational chemical graph theory , 1990 .

[27]  M. Karelson,et al.  QSPR: the correlation and quantitative prediction of chemical and physical properties from structure , 1995 .

[28]  Uko Maran,et al.  Combination of a modified scoring function with two-dimensional descriptors for calculation of binding affinities of bulky, flexible ligands to proteins. , 2006, Journal of the American Chemical Society.

[29]  D. Williams,et al.  An enthalpic component in cooperativity: the relationship between enthalpy, entropy, and noncovalent structure in weak associations. , 2001, Journal of the American Chemical Society.

[30]  M. Karelson,et al.  Correlation of Boiling Points with Molecular Structure. 1. A Training Set of 298 Diverse Organics and a Test Set of 9 Simple Inorganics , 1996 .

[31]  Alan R. Katritzky,et al.  Quantum-Chemical Descriptors in QSAR/QSPR Studies , 1996 .

[32]  Natasja Brooijmans,et al.  Molecular recognition and docking algorithms. , 2003, Annual review of biophysics and biomolecular structure.

[33]  K P Murphy.  Predicting binding energetics from structure: looking beyond DeltaG degrees. , 1999, Medicinal research reviews.

[34]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[35]  A. Hopkins,et al.  Ligand efficiency: a useful metric for lead selection. , 2004, Drug discovery today.

[36]  K. P. Murphy,et al.  Predicting binding energetics from structure: Looking beyond ΔG° , 1999 .

[37]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[38]  L. Hall,et al.  Molecular connectivity in chemistry and drug research , 1976 .

[39]  E. Freire,et al.  ITC in the post-genomic era...? Priceless. , 2005, Biophysical chemistry.

[40]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[41]  A. Balaban,et al.  Topological Indices and Related Descriptors in QSAR and QSPR , 2003 .

[42]  L Hong,et al.  Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. , 2000, Science.

[43]  G. Rishton.  Nonleadlikeness and leadlikeness in biochemical screening. , 2003, Drug discovery today.